CLINICAL_TRIALS
trial_result
· 2011-08-08
Clinical Trial Update: A Pilot Trial of the EndoBarrier™ Flow Restrictor for Glycemic Improvement in Type 2 Diabetics
Summary
A pilot clinical trial evaluating the EndoBarrier Flow Restrictor device for glycemic improvement in Type 2 diabetes has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Morphic Medical Inc. | Conditions: Type 2 Diabetes | Status: COMPLETED